Publication | Closed Access
LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
123
Citations
0
References
2020
Year
Chemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterologyPathologyCancer TreatmentOncologyRadiation OncologyCancer ResearchLba7_pr NivolumabRecurrent Gastric/gastroesophageal Junction
No additional data available for this publication yet. Check back later!